Amgen Financials
| AMGN34 Stock | BRL 60.11 0.07 0.12% |
Amgen |
Understanding current and past Amgen Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Amgen's financial statements are interrelated, with each one affecting the others. For example, an increase in Amgen's assets may result in an increase in income on the income statement.
Please note, the presentation of Amgen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amgen's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Amgen's management manipulating its earnings.
Amgen Stock Summary
Amgen competes with Deutsche Bank, Dell Technologies, Livetech, Lupatech, and Micron Technology. Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California. AMGEN DRN operates under Drug ManufacturersGeneral classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 24200 people.| Instrument | Brazil Stock View All |
| Exchange | Sao Paulo Exchange |
| Business Address | One Amgen Center |
| Sector | Healthcare |
| Industry | Drug Manufacturers—General |
| Benchmark | Dow Jones Industrial |
| Website | www.amgen.com |
| Phone | 805 447 1000 |
| Currency | BRL - Brazilian Real |
You should never invest in Amgen without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Amgen Stock, because this is throwing your money away. Analyzing the key information contained in Amgen's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Amgen Key Financial Ratios
Amgen's financial ratios allow both analysts and investors to convert raw data from Amgen's financial statements into concise, actionable information that can be used to evaluate the performance of Amgen over time and compare it to other companies across industries.| Return On Equity | 1.26 | |||
| Return On Asset | 0.0997 | |||
| Beta | 0.63 | |||
| Z Score | 10.8 | |||
| Last Dividend Paid | 7.76 |
Amgen Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Amgen's current stock value. Our valuation model uses many indicators to compare Amgen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Amgen competition to find correlations between indicators driving Amgen's intrinsic value. More Info.Amgen Inc is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.08 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Amgen Inc is roughly 12.69 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Amgen by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amgen's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Amgen Inc Systematic Risk
Amgen's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Amgen volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Amgen Inc correlated with the market. If Beta is less than 0 Amgen generally moves in the opposite direction as compared to the market. If Amgen Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Amgen Inc is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Amgen is generally in the same direction as the market. If Beta > 1 Amgen moves generally in the same direction as, but more than the movement of the benchmark.
Amgen December 4, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Amgen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Amgen Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Amgen Inc based on widely used predictive technical indicators. In general, we focus on analyzing Amgen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Amgen's daily price indicators and compare them against related drivers.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 12.18 | |||
| Value At Risk | (5.48) | |||
| Potential Upside | 2.9 |
Complementary Tools for Amgen Stock analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |